Literature DB >> 28838591

Effects of serum phosphorus on vascular calcification in a healthy, adult population: A systematic review.

Kristin Sheridan1, John V Logomarsino2.   

Abstract

Cardiovascular disease has been associated with elevated serum phosphorus levels, which have been associated with cardiovascular mortality. This is commonly seen in the chronic kidney disease (CKD) population where studies have shown that high phosphorus levels cause coronary artery calcification. Although studies have independently associated vascular stiffness and serum phosphorus in those with and without CKD, there are fewer data in individuals without CKD. Therefore, the aim of this systematic review was to analyze whether serum phosphorus levels are associated with cardiovascular calcification in healthy individuals. A systematic review of the literature that was conducted revealed 10 articles, all cross-sectional studies, that met eligibility criteria. These criteria were peer-reviewed studies on a healthy, adult population written in the English language. Studies lacking data on serum phosphorus and measured to assess its association with vascular calcification were excluded. Studies on subjects with CKD, other chronic diseases, or on children were also excluded. Of the 10 studies located, 8 indicated an association between serum phosphorus and vascular calcification. One study did not indicate an association. One study indicated a statistically significant association between serum phosphorus and vascular calcification prevalence, but not incidence. Studies were limited since no randomized controlled trials were available. This systematic review generates gaps in research. Due to considerable amounts of phosphorus additives in the food supply, there may be a connection to dietary phosphorus and vascular calcification. Additionally, phosphorus binders may assist in the prevention of vascular calcification but have not been studied in a healthy population. Further study on both dietary phosphorus restriction and phosphorus binders is needed. While 8 out of 10 cross-sectional studies found an association in this systematic review, the topic of vascular calcification and serum phosphorus needs further study if a cause and effect relationship is to be detected.
Copyright © 2017 Society for Vascular Nursing, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28838591     DOI: 10.1016/j.jvn.2017.01.003

Source DB:  PubMed          Journal:  J Vasc Nurs        ISSN: 1062-0303


  5 in total

1.  Acroosteolysis and bone metabolism parameters distinguish female patients with limited systemic sclerosis with and without calcinosis: a case control study.

Authors:  Marilia M Sampaio-Barros; Lorena C M Castelo Branco; Liliam Takayama; Marco Antonio G Pontes Filho; Percival D Sampaio-Barros; Rosa Maria R Pereira
Journal:  Clin Rheumatol       Date:  2019-06-19       Impact factor: 2.980

2.  Arterial Stiffness Determinants for Primary Cardiovascular Prevention among Healthy Participants.

Authors:  Alexandre Vallée
Journal:  J Clin Med       Date:  2022-04-29       Impact factor: 4.964

3.  Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Role of Fibroblast Growth Factor 23- Phosphate Axis.

Authors:  Yaser Ammar; Amira Mohamed; Gihane Khalil; Dalia Maharem
Journal:  Int J Nephrol Renovasc Dis       Date:  2021-08-27

Review 4.  IL-1β in atherosclerotic vascular calcification: From bench to bedside.

Authors:  Jialing Shen; Ming Zhao; Chunxiang Zhang; Xiaolei Sun
Journal:  Int J Biol Sci       Date:  2021-10-22       Impact factor: 6.580

5.  Lower Risk of Cardiovascular Events in Adult Patients with Chronic Hypoparathyroidism Treated with rhPTH(1-84): A Retrospective Cohort Study.

Authors:  Olulade Ayodele; Fan Mu; Richard Berman; Elyse Swallow; Lars Rejnmark; Elvira O Gosmanova; Sanjiv Kaul
Journal:  Adv Ther       Date:  2022-06-11       Impact factor: 4.070

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.